Nioxin PRO CLINICAL SCALP RECOVERY purifying

Manufacturer
Wella Operations US LLC
Effective date
2025-11-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 01:18:00

Label at a glance#

ProductNioxin PRO CLINICAL SCALP RECOVERY purifying
Active ingredientPYRITHIONE ZINC
Label structure10 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Pyrithione zinc 1%

OTC - PURPOSE SECTION

Purpose

Anti-dandruff

INDICATIONS & USAGE SECTION

Uses

  • Helps prevent recurrence of flaking and itching associated with dandruff.

WARNINGS SECTION

Warnings

For external use only.

OTC - WHEN USING SECTION

When using this product

  • Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

OTC - WHEN USING SECTION

Stop use and ask a doctor if

  • Condition worsens or does not improve after regular use of this product as directed.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • For best results use at least twice a week or as directed by a doctor.
  • Massage on to wet scalp and hair. Rinse. Repeat if desired.

INACTIVE INGREDIENT SECTION

Inactive ingredients water, sodium laureth sulfate, PEG-3 distearate, sodium laureth-8 sulfate, sodium chloride, cocamidopropyl betaine, sodium benzoate, acrylates/steareth-20 methacrylate copolymer, magnesium laureth sulfate, magnesium laureth-8 sulfate, sodium oleth sulfate, fragrance, mentha arvensis leaf oil, citric acid, magnesium oleth sulfate, polyquaternium-10, sodium hydroxide, propylene glycol, benzoic acid, mentha piperita oil, sodium polynaphthalenesulfonate, linalool, hexyl cinnamal, camellia sinensis leaf extract, limonene, geraniol, faex extract/yeast extract/extrait de levure, cellulose gum, biotin, lecithin, niacinamide, panthenol, tocopheryl acetate, ethoxydiglycol, methylisothiazolinone, methylparaben, glucose, propylparaben, lactic acid, achillea millefolium extract, betula alba leaf extract, equisetum arvense extract, rosmarinus officinalis (rosemary) leaf extract, salvia officinalis (sage) leaf extract, urtica dioica (nettle) extract, potassium sorbate.

SPL UNCLASSIFIED SECTION

NIOXIN SCALP RECOVERY™

PURIFYING SHAMPOO

ANTI-DANDRUFF SHAMPOO THAT HELPS RELIEVE AND PREVENT SYMPTOMS OF DANDRUFF

WITH REGULAR USE

MADE IN USA WITH IMPORTED PARTS

Dist. Wella Operations US LLC, Calabasas, CA 91302

www.nioxin.com

OTC - QUESTIONS SECTION

Questions?

1-800-935-5273

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

nioxin®

PRO CLINICAL

SCALP RECOVERY™

purifying shampoo

FOR ANTI-DANDRUFF

FOR ITCHY, FLAKY SCALP COMBATS DANDRUFF FROM THE 1 ST USE WITH PYRITHIONE ZINC.

CLINICALLY & DERMATOLOGICALLY TESTED

200 mL | 6.7 FL OZ

82157-011-20_front82157-011-20_front

82157-011-20_Back82157-011-20_Back

nioxin®

PRO CLINICAL

SCALP RECOVERY™

purifying shampoo

FOR ANTI-DANDRUFF

FOR ITCHY, FLAKY SCALP COMBATS DANDRUFF FROM THE 1 ST USE WITH PYRITHIONE ZINC.

CLINICALLY & DERMATOLOGICALLY TESTED

1L | 33.8 FL OZ

82157-011-10_Front82157-011-10_Front

82157-011-10_Back82157-011-10_Back

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1487080NIOXIN 1 % Medicated ShampooPSN2
209884zinc pyrithione 1 % Medicated ShampooPSN2
1487080zinc pyrithione 10 MG/ML Medicated Shampoo [Nioxin]SBD2
209884zinc pyrithione 10 MG/ML Medicated ShampooSCD2
1487080Nioxin 1 % Medicated ShampooSY2
1487080Nioxin 10 MG/ML ConditionerSY2
1487080Nioxin 10 MG/ML Medicated ShampooSY2
209884zinc pyrithione 1 % Medicated ConditionerSY2
209884zinc pyrithione 1 % Medicated ShampooSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82157-011-10Nioxin PRO CLINICAL SCALP RECOVERY purifying1000 mL in 1 BOTTLE, PLASTICSHAMPOO10002
82157-011-20Nioxin PRO CLINICAL SCALP RECOVERY purifying200 mL in 1 BOTTLE, PLASTICSHAMPOO2002

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 52 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82157-01182157-011-10, 82157-011-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 2 · 51 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Nioxin PRO CLINICAL SCALP RECOVERY purifyingPYRITHIONE ZINCWella Operations US LLC316c61e9-7cdf-a548-e063-6294a90ab7c32025-11-25WarningsExact identifier
ndc (package): 82157-011-10
ndc (package): 82157-011-20
ndc (product): 82157-011
ndc11 (package): 82157001110
ndc11 (package): 82157001120
spl id: 44746d42-41d8-e499-e063-6394a90aac2d
spl set id: 316c61e9-7cdf-a548-e063-6294a90ab7c3
nioxin PRO CLINICAL SCALP RECOVERYPYRITHIONE ZINCWella Operations US LLC31bf4f7f-8228-7433-e063-6394a90a2f5f2025-11-25WarningsExact identifier
ndc (package): 82157-011-20
ndc11 (package): 82157001120

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.